ArticleBioMed research international2013

FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents.

Luisa Guidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.